Luteolin inhibited hydrogen peroxide-induced vascular smooth muscle cells proliferation and migration by suppressing the Src and Akt signalling pathways

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 4, 2012, Pages 597-603

  Lang, Yasong ^a   Chen, Dan ^a   Li, Dongye ^a   Zhu, Manyi ^a   Xu, Tongda ^a   Zhang, Tian ^a   Qian, Wenhao ^a   Luo, Yuanyuan ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

luteolin; migration; proliferation; vascular smooth muscle cells (VSMCs)

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HYDROGEN PEROXIDE; LUTEOLIN; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; TYROSINE KINASE SRC; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; NONHUMAN; PROCEDURES CONCERNING CELLS; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; TRANSWELL MIGRATION ASSAY; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HYDROGEN PEROXIDE; LUTEOLIN; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84859104481     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01438.x     Document Type: Article

References (32)

1. Doran AC, et al,. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 812-819. (Pubitemid 351544093)
2. Gorenne I, et al,. Vascular smooth muscle cell senescence in atherosclerosis. Cardiovasc Res 2006; 72: 9-17. (Pubitemid 44310633)
3. Stephens JW, et al,. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009; 202: 321-329.
4. Heistad DD, et al,. Novel aspects of oxidative stress in cardiovascular diseases. Circ J 2009; 73: 201-207.
5. Antoniades C, et al,. Targeting redox signaling in the vascular wall: from basic science to clinical practice. Curr Pharm Des 2009; 15: 329-342.
6. Ushio-Fukai M, Alexander RW,. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 2004; 264: 85-97. (Pubitemid 39366107)
7. Wu L, et al,. Proliferative inhibition of danxiongfang and its active ingredients on rat vascular smooth muscle cell and protective effect on the VSMC damage induced by hydrogen peroxide. J Ethnopharmacol 2009; 126: 197-206.
8. Mehdi MZ, et al,. Role of receptor and nonreceptor protein tyrosine kinases in H2O2-induced PKB and ERK1/2 signaling. Cell Biochem Biophys 2007; 47: 1-10. (Pubitemid 46570693)
9. Touyz RM, Schiffrin EL,. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004; 122: 339-352. (Pubitemid 39506592)
10. Panchenko MP, et al,. Up-regulation of a hydrogen peroxide-responsive pre-mRNA binding protein in atherosclerosis and intimal hyperplasia. Cardiovasc Pathol 2009; 18: 167-172.
11. Limon-Pacheco J, Gonsebatt ME,. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res 2009; 674: 137-147.
12. Lopez-Lazaro M,. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 2009; 9: 31-59.
13. Yamboliev IA, et al,. PI3-kinases and Src kinases regulate spreading and migration of cultured VSMCs. Am J Physiol Cell Physiol 2001; 281: C709-C718.
14. Zhao H, et al,. 7-Difluoromethyl-5,4-dimethoxygenistein, a novel genistein derivative, has therapeutic effects on atherosclerosis in a rabbit model. J Cardiovasc Pharmacol 2009; 54: 412-420.
15. Cha BY, et al,. An inhibitory effect of chrysoeriol on platelet-derived growth factor (PDGF)-induced proliferation and PDGF receptor signaling in human aortic smooth muscle cells. J Pharmacol Sci 2009; 110: 105-110.
16. Benavente-Garcia O, Castillo J,. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 2008; 56: 6185-6205.
17. Song J, et al,. Luteolin inhibits lysophosphatidylcholine-induced apoptosis in endothelial cells by a calcium/mithocondrion/caspases-dependent pathway. Planta Med 2010; 76: 433-438.
18. Blanc A, et al,. Synchronous activation of ERK 1/2, p38mapk and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease (review). Int J Mol Med 2003; 11: 229-234.
19. Miyamoto S, et al,. Nuclear and mitochondrial signalling Akts in cardiomyocytes. Cardiovasc Res 2009; 82: 272-285.
20. Fernandez-Hernando C, et al,. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab 2007; 6: 446-457. (Pubitemid 350163050)
21. Fernandez-Hernando C, et al,. Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 2033-2040.
22. Weber DS, et al,. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res 2004; 94: 1219-1226. (Pubitemid 38656408)
23. Taniyama Y, et al,. Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions. Mol Cell Biol 2003; 23: 8019-8029. (Pubitemid 37377495)
24. Reddy MA, et al,. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2009; 29: 387-393.
25. Sayeski PP, Ali MS,. The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation. Exp Cell Res 2003; 287: 339-349. (Pubitemid 37323846)
26. Gerthoffer WT,. Mechanisms of vascular smooth muscle cell migration. Circ Res 2007; 100: 607-621. (Pubitemid 46594875)
27. Chamley-Campbell J, et al,. The smooth muscle cell in culture. Physiol Rev 1979; 59: 1-61. (Pubitemid 9106924)
28. Reddy MA, et al,. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 2006; 281: 13685-13693. (Pubitemid 43855284)
29. Berk BC, Corson MA,. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res 1997; 80: 607-616. (Pubitemid 27181343)
30. Terao J,. Dietary flavonoids as antioxidants. Forum Nutr 2009; 61: 87-94.
31. Pinkaew D, et al,. Morelloflavone blocks injury-induced neointimal formation by inhibiting vascular smooth muscle cell migration. Biochim Biophys Acta 2009; 1790: 31-39.
32. Bagli E, et al,. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3-kinase activity. Cancer Res 2004; 64: 7936-7946. (Pubitemid 39446927)